Two Decades of Overuse and Underuse of Interventions for Primary and Secondary Prevention of Cardiovascular Diseases: A Systematic Review

Brodersen, 2018, Overdiagnosis: what it is and what it isn't, BMJ Evid-Based Med, 23, 1, 10.1136/ebmed-2017-110886 Morgan, 2016, 2016 update on medical overuse: a systematic review, JAMA Int Med, 176, 1687, 10.1001/jamainternmed.2016.5381 O'Sullivan, 2018, Overtesting and undertesting in primary care: a systematic review and meta-analysis, BMJ open, 8 Chalmers, 2017, Quantifying low-value care: a patient-centric versus service-centric lens, BMJ Qual Saf, 10, 855, 10.1136/bmjqs-2017-006678 Lyu, 2017, Overtreatment in the united states, PloS one, 12, 10.1371/journal.pone.0181970 Evans, 2013, Waste, economists and American healthcare, Healthc Policy, 9, 12 Brodersen, 2016, Research on medical overuse: Overdiagnosis and overtreatment in family medicine and primary care, Euro J Gen Pract, 22, 278, 10.1080/13814788.2016.1216542 Schleicher, 2018, Medication overuse in oncology: current trends and future implications for patients and society, Lancet Oncol, 19, e200, 10.1016/S1470-2045(18)30099-8 Korenstein, 2012, Overuse of health care services in the United States: an understudied problem, Arch Intern Med, 172, 171, 10.1001/archinternmed.2011.772 Roth, 2020, Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study, J Am Coll Cardiol, 76, 2982, 10.1016/j.jacc.2020.11.010 Grilli, 2018, Overuse in cancer care: do European studies provide information useful to support policies?, Health Res Policy Syst, 16, 12, 10.1186/s12961-018-0287-z Cardona, 2022, Guideline adherence as an indicator of the extent of antithrombotic overuse and underuse: a systematic review, Global Heart, 17, 55, 10.5334/gh.1142 National Health Service. England, UK. Cardiovascular disease 2021 [Available from: https://www.nhs.uk/conditions/cardiovascular-disease/. Accessed 12 October 2022. 2021 Roth, 2020, Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study, J Am College Cardiol, 76, 2982, 10.1016/j.jacc.2020.11.010 Chalmers, 2017, Quantifying low-value care: a patient-centric versus service-centric lens, BMJ Qual Saf, 26, 855, 10.1136/bmjqs-2017-006678 Morgan, 2016, 2016 update on medical overuse: a systematic review, JAMA Intern Med, 176, 1687, 10.1001/jamainternmed.2016.5381 O'Sullivan, 2018, Overtesting and undertesting in primary care: a systematic review and meta-analysis, BMJ Open, 8 Krithikadatta, 2014, Normal distribution, J Conserv Dent, 17, 96, 10.4103/0972-0707.124171 Ross, 2021, 221 Clark, 2020, A full systematic review was completed in 2 weeks using automation tools: a case study, J Clin Epidemiol, 121, 81, 10.1016/j.jclinepi.2020.01.008 Hoy, 2012, Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement, J Clin Epidemiol, 65, 934, 10.1016/j.jclinepi.2011.11.014 Rachamin, 2020, Guideline concordance of statin treatment decisions: a retrospective cohort study, J Clin Med, 9, 19, 10.3390/jcm9113719 Bertoni, 2009, Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial, Arch Int Med, 169, 678, 10.1001/archinternmed.2009.44 Stitgen, 2015, Adherence to preoperative cardiac clearance guidelines in hip fracture patients, J Orthop Trauma, 29, 500, 10.1097/BOT.0000000000000381 D'Souza, 2019, Assessment of professionals' adherence to joint national committee 8 guidelines in the management of hypertension, Asian J Pharm Clin Res, 12, 101, 10.22159/ajpcr.2019.v12i1.28451 Cascino, 2017, Guideline concordance of new statin prescriptions: who got a statin?, Am J Manag Care, 23, 528 Abookire, 2001, Use and monitoring of "statin" lipid-lowering drugs compared with guidelines, Arch Intern Med, 161, 53, 10.1001/archinte.161.1.53 Allen-Tice, 2020, Pediatric cholesterol screening practices in 9- to 11-year-olds in a large midwestern primary care setting, J Clin Lipidol, 14, 224, 10.1016/j.jacl.2020.01.013 Kontsevaya, 2020, Management of patients with acute ST-segment elevation myocardial infarction in Russian hospitals adheres to international guidelines, Open Heart, 7, 10.1136/openhrt-2019-001134 Buerge, 2020, Doing simple things well: practice advisory implementation reduces atrial fibrillation after cardiac surgery, J Cardiothorac Vasc Anesth, 34, 2913, 10.1053/j.jvca.2020.06.078 Ramsaran, 2019, Adherence to blood cholesterol treatment guidelines among physicians managing patients with atherosclerotic cardiovascular disease, Am J Cardiol, 124, 169, 10.1016/j.amjcard.2019.04.017 Mu, 2019, Adherence to treatment guidelines in heart failure patients in the top end region of northern territory, Heart Lung Circ, 28, 1042, 10.1016/j.hlc.2018.06.1038 Feng, 2020, Differences in cardiovascular care between adults with and without opioid prescriptions in the United States, J Am Heart Assoc, 9, 10.1161/JAHA.120.015961 Hosseinzadeh-Shanjani, 2019, Adherence of cardiologist physicians to the American Heart Association guideline in approach to risk factors of cardiovascular diseases: an experience from a teaching hospital, ARYA Atheroscler, 15, 38 Schonberger, 2020, Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients, Prev Med Rep, 18 Salami, 2017, National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey, JAMA Cardiol, 2, 56, 10.1001/jamacardio.2016.4700 Musich, 2019, Underutilization of statin therapy for secondary prevention of cardiovascular disease among older adults, Popul Health Manag, 22, 74, 10.1089/pop.2018.0051 Nordestgaard, 2013, Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, 34, 3478, 10.1093/eurheartj/eht273 Gidding, 2015, The agenda for familial hypercholesterolemia: a scientific statement from the American heart association, Circulation, 132, 2167, 10.1161/CIR.0000000000000297 Borne, 2019, Potential statin overuse in older patients: a retrospective cross-sectional study using French health insurance databases, Drugs Aging, 36, 947, 10.1007/s40266-019-00695-4 Barry, 2007, START (screening tool to alert doctors to the right treatment)–an evidence-based screening tool to detect prescribing omissions in elderly patients, Age Ageing, 36, 632, 10.1093/ageing/afm118 Gallagher, 2008, Screening tool of older person's prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int J Clin Pharmacol Ther, 46, 72, 10.5414/CPP46072 Ponte-Márquez, 2017, Potentially inappropriate antihypertensive prescriptions to elderly patients: results of a prospective, observational study, Drugs Aging, 34, 453, 10.1007/s40266-017-0452-z 2012, American geriatrics society 2012 beers criteria update expert panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, 60, 616 Walker, 2021, Avoiding harm from overprescribing: What are the challenges and how do we overcome them?, Brit J Clin Pharmacol, 87, 6, 10.1111/bcp.14696 Yebyo, 2018, Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts, BMC Cardiovasc Disord, 18, 97, 10.1186/s12872-018-0838-9 Montgomery, 2008, Do advertisements for antihypertensive drugs in Australia promote quality prescribing? a cross-sectional study, BMC Public Health, 8, 167, 10.1186/1471-2458-8-167 Hassan, 2016, Why are statin prescribing guidelines for primary prevention not always followed in primary care?, Br J Gen Pract, 66, 536, 10.3399/bjgp16X687481 Kedward, 2003, A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care, Br J Gen Pract, 53, 684 Irawati, 2020, Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia, BMJ Open, 10, 10.1136/bmjopen-2019-035098 Bradley, 2019, Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry, J Am Heart Assoc, 8, 10.1161/JAHA.118.011765 Sutton, 2020, An overview of clinical decision support systems: benefits, risks, and strategies for success, NPJ Digital Med, 3, 17, 10.1038/s41746-020-0221-y 2015, NICE Guideline, No. 5. 10, Patient decision aids used in consultations involving medicines Yebyo, 2019, Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: a modeling study, Ann Intern Med, 170, 1, 10.7326/M18-1279 Mansfield, 2006, Educating health professionals about drug and device promotion: advocates' recommendations, PLoS Med, 3, e451, 10.1371/journal.pmed.0030451 Levinson, 2015, “Choosing Wisely”: a growing international campaign, BMJ Quality Safety, 24, 167, 10.1136/bmjqs-2014-003821 Chok, 2018, An echo to Choosing Wisely (®) in Switzerland, Int J Gen Med, 11, 167, 10.2147/IJGM.S155544 2010, Institute of medicine roundtable on evidence-based, medicine